14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ISRG vs NOW: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ISRG Overall Winner
6-Pillar Tally: ISRG 5 – 1 NOW
Matrix Metrics: ISRG 8 – 2 NOW
As of Nov 20, 2026, Intuitive Surgical Inc. (ISRG) is the stronger overall head-to-head candidate over Servicenow, Inc. (NOW) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ISRG carries a Unified Composite Score of 43.8/100 (HOLD) at $399.05 (32.0x Forward P/E, 31.7% operating margin), whereas NOW carries 54.2/100 (HOLD) at $87.61 (18.2x Forward P/E, 12.8% operating margin).
Composite vs. Pillar Nuance: While NOW currently prints a higher short-term Unified Composite Score (54.2/100 HOLD vs. ISRG 43.8/100 HOLD), ISRG captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (31.7% vs. 12.8% operating margin) and revenue trajectory (+21.7% vs. +20.5% YoY).
Technical & Structure Timing Caution: ISRG trades in a Neutral technical trend (SURGE options phase, RSI 35.1); meanwhile NOW is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 24.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Medical Instruments & Supplies value chain with $141.2B market capitalization and 31.7% operating margin.
OpEx & R&D Reinvestment34.9% of Rev ($4.04B)
90D Engineering Disclosures0 Published · Robot Manipulation
NOW Moat ProfileEcosystem & Network-Effect Moat
Software - Application Operator
Competes within the Software - Application value chain with $92.2B market capitalization and 12.8% operating margin.
OpEx & R&D Reinvestment60.3% of Rev ($9.30B)
90D Engineering Disclosures0 Published · Multi-Agent / Agentic AI
Investor FAQ ISRG vs NOW Key Questions & Quantitative Answers
As of Nov 20, 2026, Intuitive Surgical Inc. (ISRG) is the stronger overall head-to-head candidate over Servicenow, Inc. (NOW) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ISRG carries a Unified Composite Score of 43.8/100 (HOLD) at $399.05 (32.0x Forward P/E, 31.7% operating margin), whereas NOW carries 54.2/100 (HOLD) at $87.61 (18.2x Forward P/E, 12.8% operating margin). Composite vs. Pillar Nuance: While NOW currently prints a higher short-term Unified Composite Score (54.2/100 HOLD vs. ISRG 43.8/100 HOLD), ISRG captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (31.7% vs. 12.8% operating margin) and revenue trajectory (+21.7% vs. +20.5% YoY). Technical & Structure Timing Caution: ISRG trades in a Neutral technical trend (SURGE options phase, RSI 35.1); meanwhile NOW is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 24.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ISRG leads the Growth & Scale pillar: ISRG posts +21.7% YoY revenue growth and -23.6% YoY earnings growth on $11.6B TTM revenue (66.6% gross margin, 31.7% operating margin), compared with NOW at +20.5% YoY revenue growth and -44.2% YoY earnings growth on $15.4B TTM revenue (73.1% gross margin, 12.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ISRG cumulative revenue shifted +170.4% while NOW shifted +408.8%. In operating R&D and SG&A reinvestment, ISRG deploys 34.9% of Rev ($4.04B) (0 90-day corporate R&D disclosures) versus 60.3% of Rev ($9.30B) (0 disclosures) for NOW.
NOW screens cheaper on headline valuation multiples. ISRG trades at 32.0x Forward P/E, 49.2x Trailing P/E, 1.90x PEG, and 12.2x EV/Revenue (31.1% FCF margin), whereas NOW trades at 18.2x Forward P/E, 63.9x Trailing P/E, 0.71x PEG, and 6.4x EV/Revenue (30.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ISRG (17.9% ROE) versus NOW (11.8% ROE) capital efficiency.
In options market volatility and institutional positioning, ISRG carries 132.6% implied volatility (69th %ile, Elevated (60th–80th %ile)), a 0.84x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.81β · 44% Vol realized risk). By comparison, NOW carries 56.8% implied volatility (12th %ile, Compressed (<25th %ile)), a 1.41x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.86β · 96% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.